Ellis Ronald J. Jr. 4
4 · TELA Bio, Inc. · Filed Nov 13, 2019
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Ellis Ronald J. Jr.
Director10% Owner
Transactions
- Conversion
Series B Preferred Stock
2019-11-13−14,329,052→ 0 total(indirect: By IRA)→ Common Stock (580,357 underlying) - Conversion
Common Stock
2019-11-13+580,357→ 774,056 total(indirect: By IRA)
Footnotes (3)
- [F1]Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
- [F2]Reflects 193,699 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
- [F3]Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.